What does CUSIP 90400D108 represent in this 13F holders report?

CUSIP 90400D108 is the security identifier for RARE - Ultragenyx Pharmaceutical Inc. - COMMON STOCK used to aggregate holder disclosures.

How many institutions held RARE - Ultragenyx Pharmaceutical Inc. - COMMON STOCK in Q2 2022?

210 institutional investors reported RARE - Ultragenyx Pharmaceutical Inc. - COMMON STOCK for Q2 2022. Use the holders table for investor-level position and value details.

Ultragenyx Pharmaceutical Inc. - COMMON STOCK (RARE)

CUSIP: 90400D108

Q2 2022 13F Holders as of 30 Jun 2022

Type / Class: Equity / COMMON STOCK
Shares outstanding: 98,459,627
Total 13F shares: 67,540,585
Share change: +595,841
Total reported value: $4,030,154,883
Put/Call ratio: 113%
Price per share: $59.66
Number of holders: 210
Value change: +$24,063,212
Number of buys: 110
Number of sells: 110

Quarterly Holders Quick Answers

What is CUSIP 90400D108?
CUSIP 90400D108 identifies RARE - Ultragenyx Pharmaceutical Inc. - COMMON STOCK in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2022
Previous quarter: Q1 2022

Recent filing periods for CUSIP 90400D108:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of RARE - Ultragenyx Pharmaceutical Inc. - COMMON STOCK (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	12%	11,884,786	$863,073,000	—	31 Mar 2022	13F
VANGUARD GROUP INC	13F	Company	6.1%	5,963,374	$433,060,000	—	31 Mar 2022	13F
FEDERATED HERMES, INC.	13F	Company	4.1%	3,987,728	$289,589,000	—	31 Mar 2022	13F
BlackRock Finance, Inc.	13F	Company	3.5%	3,440,671	$249,862,000	—	31 Mar 2022	13F
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	3.4%	3,370,245	$244,747,000	—	31 Mar 2022	13F
Capital International Investors	13F	Company	3.4%	3,345,026	$242,891,000	—	31 Mar 2022	13F
Clearbridge Investments, LLC	13F	Company	2.9%	2,863,921	$207,978,000	—	31 Mar 2022	13F
Capital World Investors	13F	Company	2.8%	2,765,793	$200,852,000	—	31 Mar 2022	13F
ALKEON CAPITAL MANAGEMENT LLC	13F	Company	2.4%	2,368,130	$171,973,000	—	31 Mar 2022	13F
STATE STREET CORP	13F	Company	2%	1,948,684	$141,513,000	—	31 Mar 2022	13F
ALLIANCEBERNSTEIN L.P.	13F	Company	1.4%	1,373,429	$99,738,000	—	31 Mar 2022	13F
RTW INVESTMENTS, LP	13F	Company	1.4%	1,373,284	$99,728,000	—	31 Mar 2022	13F
CITADEL ADVISORS LLC	13F	Company	1.3%	1,315,032	$95,498,000	—	31 Mar 2022	13F
FMR LLC	13F	Company	1.3%	1,255,524	$91,177,000	—	31 Mar 2022	13F
MACQUARIE GROUP LTD	13F	Company	1.1%	1,078,024	$78,287,000	—	31 Mar 2022	13F
Rock Springs Capital Management LP	13F	Company	1%	1,028,109	$74,661,000	—	31 Mar 2022	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.92%	902,900	$65,568,000	—	31 Mar 2022	13F
Avidity Partners Management LP	13F	Company	0.88%	869,000	$63,107,000	—	31 Mar 2022	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.78%	767,241	$55,717,000	—	31 Mar 2022	13F
Bank of New York Mellon Corp	13F	Company	0.77%	755,032	$54,829,000	—	31 Mar 2022	13F
FIRST TRUST ADVISORS LP	13F	Company	0.74%	723,758	$52,559,000	—	31 Mar 2022	13F
ADAGE CAPITAL PARTNERS GP, L.L.C.	13F	Company	0.71%	700,000	$50,834,000	—	31 Mar 2022	13F
NORGES BANK	13F	Company	0.67%	662,676	$48,123,531	—	31 Mar 2022	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.55%	540,744	$39,269,000	—	31 Mar 2022	13F
SUVRETTA CAPITAL MANAGEMENT, LLC	13F	Company	0.53%	525,100	$38,133,000	—	31 Mar 2022	13F
D. E. Shaw & Co., Inc.	13F	Company	0.49%	484,338	$35,173,000	—	31 Mar 2022	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	0.47%	463,996	$33,693,000	—	31 Mar 2022	13F
BAKER BROS. ADVISORS LP	13F	Company	0.45%	444,444	$32,276,000	—	31 Mar 2022	13F
First Light Asset Management, LLC	13F	Company	0.44%	437,512	$31,772,000	—	31 Mar 2022	13F
MARSHALL WACE, LLP	13F	Company	0.39%	385,453	$27,993,000	—	31 Mar 2022	13F
DEUTSCHE BANK AG\	13F	Company	0.37%	365,528	$26,545,000	—	31 Mar 2022	13F
TD ASSET MANAGEMENT INC	13F	Company	0.36%	358,341	$26,023,000	—	31 Mar 2022	13F
NORTHERN TRUST CORP	13F	Company	0.34%	337,696	$24,523,000	—	31 Mar 2022	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.34%	335,483	$24,364,000	—	31 Mar 2022	13F
Point72 Asset Management, L.P.	13F	Company	0.32%	318,497	$23,129,000	—	31 Mar 2022	13F
LORD, ABBETT & CO. LLC	13F	Company	0.32%	313,744	$22,784,000	—	31 Mar 2022	13F
JPMORGAN CHASE & CO	13F	Company	0.31%	301,143	$21,869,000	—	31 Mar 2022	13F
FRED ALGER MANAGEMENT, LLC	13F	Company	0.28%	279,773	$20,317,000	—	31 Mar 2022	13F
MORGAN STANLEY	13F	Company	0.25%	244,739	$17,773,000	—	31 Mar 2022	13F
Nuveen Asset Management, LLC	13F	Company	0.26%	258,145	$17,755,000	—	31 Mar 2022	13F
Avoro Capital Advisors LLC	13F	Company	0.23%	230,000	$16,703,000	—	31 Mar 2022	13F
AXA S.A.	13F	Company	0.23%	228,053	$16,561,209	—	31 Mar 2022	13F
ORBIMED ADVISORS LLC	13F	Company	0.23%	227,600	$16,528,000	—	31 Mar 2022	13F
EMERALD ADVISERS, LLC	13F	Company	0.23%	223,952	$16,263,000	—	31 Mar 2022	13F
Boxer Capital, LLC	13F	Company	0.2%	200,000	$14,524,000	—	31 Mar 2022	13F
NEW YORK STATE COMMON RETIREMENT FUND	13F	Company	0.19%	185,040	$13,438,000	—	31 Mar 2022	13F
EMERALD MUTUAL FUND ADVISERS TRUST	13F	Company	0.19%	182,204	$13,232,000	—	31 Mar 2022	13F
FRANKLIN RESOURCES INC	13F	Company	0.18%	179,197	$13,013,000	—	31 Mar 2022	13F
PUBLIC EMPLOYEES RETIREMENT ASSOCIATION OF COLORADO	13F	Company	0.16%	153,716	$11,163,000	—	31 Mar 2022	13F
Swiss National Bank	13F	Company	0.16%	153,152	$11,122,000	—	31 Mar 2022	13F

Institutional Holders of Ultragenyx Pharmaceutical Inc. - COMMON STOCK (RARE) as of Q2 2022

As of 30 Jun 2022, Ultragenyx Pharmaceutical Inc. - COMMON STOCK (RARE) was held by 210 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 67,540,585 shares. The largest 10 holders included PRICE T ROWE ASSOCIATES INC /MD/, VANGUARD GROUP INC, WELLINGTON MANAGEMENT GROUP LLP, FEDERATED HERMES, INC., BlackRock Inc., Capital International Investors, Clearbridge Investments, LLC, ALKEON CAPITAL MANAGEMENT LLC, STATE STREET CORP, and Avidity Partners Management LP. This page lists 211 institutional shareholders reporting positions in this security for the Q2 2022 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2022 vs Q1 2022 Across Filers

Q1 2022 holders

227

Q2 2022 holders

210

Holder diff

-17

Investor	Q1 2022 Shares	Q2 2022 Shares	Share Diff	Share Chg %	Q1 2022 Value $	Q2 2022 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.